Anne Marie Nagy, PhD, is a senior biopharma executive with more than 25 years of global experience in clinical drug development, operational strategy, and P&L leadership across pharmaceutical and CRO organizations. She currently serves as Executive Vice President and Head of Clinilabs Europe, where she leads regional growth, oversees EU financial performance, and drives operational excellence. A proven builder of high‑performing therapeutic business units, Dr. Nagy has delivered consistent double‑digit revenue growth and strong EBITDA results, with prior senior leadership roles at TFS HealthScience, Premier Research, IQVIA, PPD, Eli Lilly, and SMB Laboratories. Her therapeutic expertise spans neuroscience, psychiatry, rare and pediatric diseases, and advanced gene therapies across Europe, the U.S., Asia‑Pacific, Latin America, and South Africa. Dr. Nagy holds a PhD in Biomedical Sciences (Summa Cum Laude) from the Free University of Brussels, completed an executive business certification program at the Stockholm School of Economics, and has served as an expert for the European Network for Women in Technology.